Cargando…
Heart disease: recruitment of MEF2 activity by β−blockers wards off cardiomyocyte death
Autores principales: | Hashemi, S, Wales, S, Miyake, T, McDermott, J C |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4632314/ https://www.ncbi.nlm.nih.gov/pubmed/26469965 http://dx.doi.org/10.1038/cddis.2015.293 |
Ejemplares similares
-
Pro-survival function of MEF2 in cardiomyocytes is enhanced by β-blockers
por: Hashemi, S, et al.
Publicado: (2015) -
Heart Failure and MEF2 Transcriptome Dynamics in Response to β-Blockers
por: Tobin, S. W., et al.
Publicado: (2017) -
Global MEF2 target gene analysis in cardiac and skeletal muscle reveals novel regulation of DUSP6 by p38MAPK-MEF2 signaling
por: Wales, Stephanie, et al.
Publicado: (2014) -
The MEF2A transcription factor interactome in cardiomyocytes
por: Moustafa, Amira, et al.
Publicado: (2023) -
β1-blocker in sepsis
por: Hasegawa, Daisuke, et al.
Publicado: (2021)